ERBB2 and neoplasm: The possible explanation was that patients with a Her2-positive smaller tumor size still had a potential risk of relapse.27,28 Interestingly, nodal status mainly affected the prognosis of patients with HR negative subtypes including Her2 positive and TN subtypes.